US Stock MarketDetailed Quotes

MNPR Monopar Therapeutics

Watchlist

2.5800
+0.1000+4.03%

Close Aug 21 16:00 ET

2.6001
+0.0201+0.78%

Post 19:59 ET

9.08MMarket Cap-1121P/E (TTM)

Monopar Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

20.21%-1.68M

27.11%-1.66M

-8.71%-7.86M

-18.75%-1.55M

9.71%-1.94M

-60.32%-2.1M

7.96%-2.27M

1.21%-7.23M

35.93%-1.3M

-10.67%-2.15M

Net income from continuing operations

22.03%-1.72M

32.59%-1.64M

20.10%-8.4M

37.37%-1.81M

18.58%-1.95M

20.37%-2.2M

0.90%-2.43M

-15.52%-10.52M

-8.05%-2.9M

2.39%-2.4M

Change In working capital

21.05%-295.88K

-9.62%-342.86K

-182.27%-1.35M

-117.17%-206.19K

-229.73%-460.22K

-134.23%-374.77K

38.74%-312.77K

417.93%1.65M

302.35%1.2M

-211.60%-139.57K

-Change in payables and accrued expense

6.99%-345.75K

-23.54%-311.24K

-190.21%-1.33M

-117.81%-213K

-79.04%-496.89K

-134.03%-371.72K

52.67%-251.92K

265.95%1.48M

251.09%1.2M

-303.62%-277.52K

-Change in other current assets

1,735.65%49.87K

41.07%-35.86K

-111.88%-20.41K

-30.08%6.81K

-72.52%36.67K

-168.64%-3.05K

-352.35%-60.84K

299.26%171.76K

123.14%9.74K

1,287.83%133.47K

-Change in other working capital

--0

--4.24K

----

---4.24K

---4.49K

--4.49K

Cash from discontinued investing activities

Operating cash flow

20.21%-1.68M

27.11%-1.66M

-8.71%-7.86M

-18.75%-1.55M

9.71%-1.94M

-60.32%-2.1M

7.96%-2.27M

1.21%-7.23M

35.93%-1.3M

-10.67%-2.15M

Investing cash flow

Cash flow from continuing investing activities

-100.08%-2.42K

0.01%-983.31K

200.19%4.93M

160.39%2.97M

-13.05K

2.95M

-983.44K

-4.92M

Net investment purchase and sale

-100.08%-2.42K

0.01%-983.31K

200.19%4.93M

160.39%2.97M

---13.05K

--2.95M

---983.44K

---4.92M

--0

Cash from discontinued investing activities

Investing cash flow

-100.08%-2.42K

0.01%-983.31K

200.19%4.93M

160.39%2.97M

---13.05K

--2.95M

---983.44K

---4.92M

--0

Financing cash flow

Cash flow from continuing financing activities

-101.55%-9.92K

295.36%3.18M

6,066.85%2.03M

141.14%334.55K

1,139.27%246.7K

1,079.50%641.18K

4,928.98%804.8K

-99.70%32.87K

1,885.09%138.74K

-137.90%-23.74K

Net common stock issuance

-100.00%-1

288.57%3.19M

1,797.07%2.07M

210.85%339.87K

--254.91K

--657.79K

--821.63K

-99.00%109.34K

--109.34K

--0

Proceeds from stock option exercised by employees

----

--0

----

-99.03%169

--0

--128

Net other financing activities

39.79%-10K

36.19%-10.74K

38.71%-46.97K

-118.10%-5.32K

65.61%-8.21K

74.64%-16.61K

-0.97%-16.83K

-21.15%-76.63K

478.28%29.4K

-139.19%-23.87K

Cash from discontinued financing activities

Financing cash flow

-101.55%-9.92K

295.36%3.18M

6,066.85%2.03M

141.14%334.55K

1,139.27%246.7K

1,079.50%641.18K

4,928.98%804.8K

-99.70%32.87K

1,885.09%138.74K

-137.90%-23.74K

Net cash flow

Beginning cash position

36.36%7.81M

-11.24%7.27M

-59.68%8.19M

-61.48%5.52M

-56.18%7.21M

-67.87%5.73M

-59.68%8.19M

21.31%20.3M

-35.92%14.32M

-32.23%16.46M

Current changes in cash

-213.10%-1.69M

122.17%543.15K

92.54%-903.32K

128.92%1.76M

21.46%-1.71M

208.52%1.49M

1.39%-2.45M

-440.08%-12.11M

-198.16%-6.08M

-11.32%-2.17M

Effect of exchange rate changes

134.27%1.49K

84.76%-1.65K

-382.92%-16.8K

82.84%-8.36K

-73.08%6.76K

-120.97%-4.35K

-1,545.37%-10.84K

-175.22%-3.48K

-2,556.46%-48.69K

313,750.00%25.11K

End cash Position

-15.17%6.12M

36.36%7.81M

-11.24%7.27M

-61.48%5.52M

-56.18%7.21M

-67.87%5.73M

-59.68%8.19M

-35.92%14.32M

Free cash flow

20.21%-1.68M

27.11%-1.66M

-8.71%-7.86M

-18.75%-1.55M

9.71%-1.94M

-60.32%-2.1M

7.96%-2.27M

1.21%-7.23M

35.93%-1.3M

-10.67%-2.15M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	20.21%-1.68M	27.11%-1.66M	-8.71%-7.86M	-18.75%-1.55M	9.71%-1.94M	-60.32%-2.1M	7.96%-2.27M	1.21%-7.23M	35.93%-1.3M	-10.67%-2.15M
Net income from continuing operations	22.03%-1.72M	32.59%-1.64M	20.10%-8.4M	37.37%-1.81M	18.58%-1.95M	20.37%-2.2M	0.90%-2.43M	-15.52%-10.52M	-8.05%-2.9M	2.39%-2.4M
Change In working capital	21.05%-295.88K	-9.62%-342.86K	-182.27%-1.35M	-117.17%-206.19K	-229.73%-460.22K	-134.23%-374.77K	38.74%-312.77K	417.93%1.65M	302.35%1.2M	-211.60%-139.57K
-Change in payables and accrued expense	6.99%-345.75K	-23.54%-311.24K	-190.21%-1.33M	-117.81%-213K	-79.04%-496.89K	-134.03%-371.72K	52.67%-251.92K	265.95%1.48M	251.09%1.2M	-303.62%-277.52K
-Change in other current assets	1,735.65%49.87K	41.07%-35.86K	-111.88%-20.41K	-30.08%6.81K	-72.52%36.67K	-168.64%-3.05K	-352.35%-60.84K	299.26%171.76K	123.14%9.74K	1,287.83%133.47K
-Change in other working capital	--0	--4.24K	----	----	----	----	----	---4.24K	---4.49K	--4.49K
Cash from discontinued investing activities
Operating cash flow	20.21%-1.68M	27.11%-1.66M	-8.71%-7.86M	-18.75%-1.55M	9.71%-1.94M	-60.32%-2.1M	7.96%-2.27M	1.21%-7.23M	35.93%-1.3M	-10.67%-2.15M
Investing cash flow
Cash flow from continuing investing activities	-100.08%-2.42K	0.01%-983.31K	200.19%4.93M	160.39%2.97M	-13.05K	2.95M	-983.44K	-4.92M	-4.92M	0
Net investment purchase and sale	-100.08%-2.42K	0.01%-983.31K	200.19%4.93M	160.39%2.97M	---13.05K	--2.95M	---983.44K	---4.92M	---4.92M	--0
Cash from discontinued investing activities
Investing cash flow	-100.08%-2.42K	0.01%-983.31K	200.19%4.93M	160.39%2.97M	---13.05K	--2.95M	---983.44K	---4.92M	---4.92M	--0
Financing cash flow
Cash flow from continuing financing activities	-101.55%-9.92K	295.36%3.18M	6,066.85%2.03M	141.14%334.55K	1,139.27%246.7K	1,079.50%641.18K	4,928.98%804.8K	-99.70%32.87K	1,885.09%138.74K	-137.90%-23.74K
Net common stock issuance	-100.00%-1	288.57%3.19M	1,797.07%2.07M	210.85%339.87K	--254.91K	--657.79K	--821.63K	-99.00%109.34K	--109.34K	--0
Proceeds from stock option exercised by employees	----	----	--0	--0	--0	----	----	-99.03%169	--0	--128
Net other financing activities	39.79%-10K	36.19%-10.74K	38.71%-46.97K	-118.10%-5.32K	65.61%-8.21K	74.64%-16.61K	-0.97%-16.83K	-21.15%-76.63K	478.28%29.4K	-139.19%-23.87K
Cash from discontinued financing activities
Financing cash flow	-101.55%-9.92K	295.36%3.18M	6,066.85%2.03M	141.14%334.55K	1,139.27%246.7K	1,079.50%641.18K	4,928.98%804.8K	-99.70%32.87K	1,885.09%138.74K	-137.90%-23.74K
Net cash flow
Beginning cash position	36.36%7.81M	-11.24%7.27M	-59.68%8.19M	-61.48%5.52M	-56.18%7.21M	-67.87%5.73M	-59.68%8.19M	21.31%20.3M	-35.92%14.32M	-32.23%16.46M
Current changes in cash	-213.10%-1.69M	122.17%543.15K	92.54%-903.32K	128.92%1.76M	21.46%-1.71M	208.52%1.49M	1.39%-2.45M	-440.08%-12.11M	-198.16%-6.08M	-11.32%-2.17M
Effect of exchange rate changes	134.27%1.49K	84.76%-1.65K	-382.92%-16.8K	82.84%-8.36K	-73.08%6.76K	-120.97%-4.35K	-1,545.37%-10.84K	-175.22%-3.48K	-2,556.46%-48.69K	313,750.00%25.11K
End cash Position	-15.17%6.12M	36.36%7.81M	-11.24%7.27M	-11.24%7.27M	-61.48%5.52M	-56.18%7.21M	-67.87%5.73M	-59.68%8.19M	-59.68%8.19M	-35.92%14.32M
Free cash flow	20.21%-1.68M	27.11%-1.66M	-8.71%-7.86M	-18.75%-1.55M	9.71%-1.94M	-60.32%-2.1M	7.96%-2.27M	1.21%-7.23M	35.93%-1.3M	-10.67%-2.15M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall